Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories Ltd. announced that its formulations manufacturing facility in Srikakulam, Andhra Pradesh, underwent a Pre-Approval Inspection by the USFDA, resulting in three observations. The company is committed to addressing these observations within the given timeline. This regulatory step is crucial for investors tracking Dr. Reddy’s compliance with international standards.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
